Planning

Covid-19 nMAB Infusion service at home

  • NHS Surrey Heartlands ICB

F01: Prior information notice (prior information only)

Notice identifier: 2024/S 000-015803

Procurement identifier (OCID): ocds-h6vhtk-0468c4

Published 20 May 2024, 10:17am



Section one: Contracting authority

one.1) Name and addresses

NHS Surrey Heartlands ICB

Block C, 1st Floor,Dukes Court, Duke Street

WOKING

KT229AE

Contact

Amber Byrne

Email

amber.byrne@nhs.net

Telephone

+44 7585996337

Country

United Kingdom

Region code

UKJ26 - East Surrey

NHS Organisation Data Service

QXU

Internet address(es)

Main address

www.surreyheartlands.org

one.3) Communication

Additional information can be obtained from the above-mentioned address

one.4) Type of the contracting authority

Other type

NHS

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Covid-19 nMAB Infusion service at home

Reference number

NMAB001

two.1.2) Main CPV code

  • 85141200 - Services provided by nurses

two.1.3) Type of contract

Services

two.1.4) Short description

This contract is for the provision of a nurse led homecare service to administer intravenous COVID-19 neutralising monoclonal antibodies to eligible community patients registered with a GP in Surrey Heartlands in line with NICE TA878.

The contract is required following notice being served since which time patients have been provided with oral antivirals with IV therapy reserved for individuals recommended by their specialist service. IV administration has needed to be delivered at a specialist centre in the absence of an infusion service at home.

The service is required as soon as feasibly possible in the interests of patients.

Surrey Heartlands ICB is intending to follow the Most Suitable Provider Process to award a contract under The Health Care Services (Provider Selection Regime) Regulations 2023.

two.1.5) Estimated total value

Value excluding VAT: £68,000

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKJ - South East (England)

two.2.4) Description of the procurement

This contract is for the provision of a nurse led homecare service to administer intravenous COVID-19 neutralising monoclonal antibodies to eligible community patients registered with a GP in Surrey Heartlands in line with NICE TA878.

Patients will have been clinically assessed by East Berkshire Primary Care Trust (EBPCT) and where necessary prescribed IV therapy due to their individual patient circumstances.

The IV therapy is dispensed and delivered by a named community pharmacy in Surrey Heartlands which will refer patients onto the home care IV administration service.

EBPC is also responsible for clinically assessing patients who may be geographically located in the Surrey Heartlands area, explicitly patients in detained estate or Mental Health wards and patients who are on holiday in the area.

The aim of the service is to ensure all patients within the ICS are able to access the provision of homecare IV fairly and equitably and that all patients referred into the service receive IV therapy within 5 days of symptom onset. Some patients may receive therapy on day 6 or 7 with the agreement of the prescribing trust.

two.2.14) Additional information

Award decision makers:

- Surrey Heartlands ICB Executive Team

- Surrey Heartlands ICB Commissioning, Contracting and Commercial Committee Meeting via remote resolution

two.3) Estimated date of publication of contract notice

3 June 2024


Section four. Procedure

four.1) Description

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No


Section six. Complementary information

six.3) Additional information

This is a Provider Selection Regime (PSR) intended approach notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.